Press Release: SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services

DZS Clinical Services announced today that SBI Pharmaceuticals, the leading expert in research, development, and manufacturing of 5-ALA, has entered into a preferred provider agreement with DZS to manage several clinical programs related to the development of 5-ALA. Bound Brook, NJ (PRWEB) July 24, 2014 As part of the long-term strategic approach, DZS expects to […]

This Week We’re Talking About: Biopharma’s challenges, Big Pharma, and Indian Clinical Trials

Challenges for biopharmas, big pharma and Indian clinical trials lead our list of hot topics this week! 1.  Timescales and sourcing comparator biologics are the biggest challenges for biopharmas running biosimilars studies. 2.  After much resistance, some big pharma companies are allowing a look at their clinical trials and patient information in order to further research and […]

Lack of Elderly Participation in Clinical Trials

Clinical Trial Participation Part 2: The second of an ongoing series of articles examining critical issues concerning clinical trial participation Lack of Elderly Participation in Clinical Trials In part two of this ongoing series, we turn to the issue of the lack of elderly participation in clinical trials. According to the Administration on Aging, there […]